Substituted Heterocyclic Ethers and Their Use in CNS Disorders
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
-
Page/Page column 28
(2009/01/24)
More Articles about upstream products of 926207-02-5